Effect of Empagliflozin on Sphingolipid Catabolism in Diabetic and Hypertensive Rats

Effect of Empagliflozin on Sphingolipid Catabolism in Diabetic and Hypertensive Rats

The profile of sphingomyelin and its metabolites shows changes in the plasma, organs, and tissues of patients with cardiovascular, renal, and metabolic diseases. The objective of this study was to investigate the effect of empagliflozin on the levels of sphingomyelin and its metabolites, as well as...

Full description

Bibliographic Details
Main Authors: Roxana Pérez-Villavicencio, Javier Flores-Estrada, Martha Franco, Bruno Escalante, Oscar Pérez-Méndez, Adriana Mercado, Rocio Bautista-Pérez
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:International Journal of Molecular Sciences
Subjects:
diabetes
angiotensin II-induced hypertension
sphingomyelin
ceramide
sphingosine
shingosine-1-P
Online Access:https://www.mdpi.com/1422-0067/23/5/2883

Similar Items

Similar Items